{"version":"1.0","type":"link","title":"Response to the letter of Peng Bai and Jun Zhang on Cost-effectiveness of Adjuvant Alectinib in ALK-positive NSCLC-Considerations for Broader Applicability.","author_name":"Supiot R 외","author_url":"https://prs-insight.online/author/Supiot%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/96407","thumbnail_width":1200,"thumbnail_height":630}